Sort   by:  
 Page size 
0
UnknownThe Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins.
Not available
S-EPMC8075977 | biostudies-literature
0
UnknownDoxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.
Not available
S-EPMC5400809 | biostudies-literature
0
UnknownUK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Not available
S-EPMC3423010 | biostudies-literature
1K
OtherBLUEPRINT
Organisation EGAO00000000072
EGAO00000000072 | EGA
1K
OtherEMBL-EBI
Organisation EGAO00000000183
EGAO00000000183 | EGA
0
UnknownSarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Not available
S-EPMC8078879 | biostudies-literature
0
UnknownA second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689 | biostudies-literature
0
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
0
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
0
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
Sort   by:  
 Page size